Abstract
FDA-Approved Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Inhibitors for Managing Rheumatoid Arthritis: A Narrative Review of the Literature
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have